Trxade Group Announces Launch of Bonum+ B2B Platform
August 11 2020 - 8:05AM
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug
procurement, delivery and healthcare
platform,
today announced that its Bonum
Health subsidiary has launched a first-of-its-kind
Business-to-Business (B2B) platform called Bonum+, which bundles
telehealth, a COVID-19 risk assessment tool and a Personal
Protective Equipment (PPE) purchasing tool, through a secure mobile
dashboard for corporate clients.
The new B2B platform eases pressure on employees
who are required to report any relevant health issues daily,
centralizing communication and contact tracing to deliver risk
scores. This allows employers to monitor employee COVID-19 risk
profiles and streamlines the ordering of new PPE as needed. An
integrated artificial intelligence (AI) tool offers health
recommendations and connects employees with board certified
physicians, as needed.
“I am proud of the entire team at Bonum Health,
a Trxade Group Company, for their efforts in launching this
innovative new service,” said Ashton Maaraba, President of Bonum
Health. “This platform resolves a fundamental trust problem
impacting employer’s safety and security policies, allowing
companies to more effectively combat COVID-19 concerns in the
workplace.”
“Looking forward, we plan to continue to expand
the breadth of services offered by Bonum Health, including adding a
digital health hub with next-generation prescription concierge
services. We believe that we are well positioned to execute upon
the immense opportunity facing us today, supporting critical public
health efforts nationwide,” concluded Maaraba.
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group,
Inc. (Nasdaq: MEDS) is an integrated drug procurement,
delivery and healthcare platform that fosters price transparency,
thereby improving profit margins for both buyers and sellers of
pharmaceuticals. Trxade Group operates across all 50 states with
the central mission of making healthcare services affordable and
accessible. Founded in 2010, Trxade Group is comprised of four
synergistic operating platforms; (1) the Trxade B2B trading
platform with 11,725 registered pharmacies, (2) Integra Pharma
Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum
Health platform offering affordable telehealth services; and (4)
the DelivMeds app, which coordinates a nationwide distribution
network through independent pharmacies or mail order delivery. For
additional information, please visit us at www.trxade.com,
www.delivmeds.com, and www.bonumhealth.com.
Forward-Looking
Statements
This press release may contain forward-looking
statements, including information about management’s view of
Trxade’s future expectations, plans and prospects, within the safe
harbor provisions under The Private Securities Litigation Reform
Act of 1995 (the “Act”). In particular, when used in the preceding
discussion, the words “may,” “could,” “expect,” “intend,” “plan,”
“seek,” “anticipate,” “believe,” “estimate,” “predict,”
“potential,” “continue,” “likely,” “will,” “would” and variations
of these terms and similar expressions, or the negative of these
terms or similar expressions are intended to identify
forward-looking statements within the meaning of the Act, and are
subject to the safe harbor created by the Act. Any statements made
in this news release other than those of historical fact, about an
action, event or development, are forward-looking statements. These
statements involve known and unknown risks, uncertainties and other
factors, which may cause the results of Trxade, its divisions and
concepts to be materially different than those expressed or implied
in such statements. These risk factors and others are included from
time to time in filings made by Trxade with the Securities and
Exchange Commission, including, but not limited to, in the “Risk
Factors” sections in its Form 10-Ks and Form 10-Qs and in its Form
8-Ks, which it has filed, and files from time to time, with the
U.S. Securities and Exchange Commission. These reports are
available at www.sec.gov. Other unknown or unpredictable
factors also could have material adverse effects on Trxade’s future
results and/or could cause our actual results and financial
condition to differ materially from those indicated in the
forward-looking statements. The forward-looking statements included
in this press release are made only as of the date hereof. Trxade
cannot guarantee future results, levels of activity, performance or
achievements. Accordingly, you should not place undue reliance on
these forward-looking statements. We undertake no obligation to
update publicly any of these forward-looking statements to reflect
actual results, new information or future events, changes in
assumptions or changes in other factors affecting forward-looking
statements, except to the extent required by applicable laws. If we
update one or more forward-looking statements, no inference should
be drawn that we will make additional updates with respect to those
or other forward-looking statements.
Investor Relations: Luke
Zimmerman Senior Vice President MZ Group - MZ North America
(949) 259-4987 MEDS@mzgroup.us www.mzgroup.us
TRxADE Health (NASDAQ:MEDS)
Historical Stock Chart
From Aug 2024 to Sep 2024
TRxADE Health (NASDAQ:MEDS)
Historical Stock Chart
From Sep 2023 to Sep 2024